Health IT Analytics June 17, 2020
NIH is expanding the scope of the All of Us precision medicine research program to better understand the impact of COVID-19.
The All of Us precision medicine research program announced that it will evaluate the spread and effects of COVID-19 through antibody testing, a survey about the pandemic’s impact, and EHR data.
All of Us will collect COVID-19 antibody data by testing blood samples from 10,000 or more participants who joined the program most recently. The team will start with samples from March 2020 and work backward until positive tests are no longer found. These tests will reveal the prevalence of COVID-19 exposure among All of Us participants, and will help researchers assess patterns across regions and communities.
This effort...
Today's Sponsors
Today's Sponsor